A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide

References

• Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Nanoemulsion as a potential ophthalmic delivery system for Dorzolamide Hydrochloride. AAPS Pharm Sci Tech 2009; 10: 808–19
   PubMed Web of Science ®Google Scholar
• Becker B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox: A preliminary report. Am J Ophthalmol 1954; 37: 13–5
   PubMed Web of Science ®Google Scholar
• Chang JN. Apparatus and methods for implanting particulate ocular implants. 2006. US Patent 2007/0293873 A1, 19 June.
   Google Scholar
• Das S, Suresh PK, Desmukh R. Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine: NBM, 2010;6:318–23.
   Google Scholar
• Draize JH, Woodard G, Calvery HO. Method for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1944; 82: 377–90
   Web of Science ®Google Scholar
• Fialho SL, da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Exp Ophthalmol 2004; 32: 626–32
   PubMed Web of Science ®Google Scholar
• Fridriksdottir H, Loftsson T, Stefansson E. Formulation and testing of methazolamide cyclodextrin eye drop solutions. J Control Release 1997; 44: 95–9
   Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine: NBM 2010; 6: 324–33
   PubMed Web of Science ®Google Scholar
• Hagerstrom H, Paulsson M, Edsman K. Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method. Eur J Pharm Sci 2000; 9: 301–9
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for Acetazolamide: In vitro and in vivo studies. AAPS Pharm Sci Tech 2007; 8: E1–E12
   PubMed Web of Science ®Google Scholar
• Huo D, Deng S, Li L, Ji J. Studies on the poly (lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm 2005; 89: 63–7
   Google Scholar
• Jonathan CJ, Norman BJ, McDonnell P. 1996. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent. US Patent 5494901, 27 February.
   Google Scholar
• Kassem MA, Abdel Rahman AA, Ghorab MM, Ahmed MB, Khalil RM. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm 2007; 340: 126–33
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular delivery: An overview. Int J Pharm 2004; 269: 1–14
   PubMed Web of Science ®Google Scholar
• Kaur IP, Smitha R, Aggarwal D, Kapil M. Acetazolamide: Future perspective in topical glaucoma therapeutics. Int J Pharm 2002; 248: 1–14
   PubMed Web of Science ®Google Scholar
• Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems–recent advances. Prog Retin Eye Res 1998; 17: 35–58
   Web of Science ®Google Scholar
• Liu DF, Jiang SM, Shen H, Qin S, Liu JJ, Zhang Q, Li R, Xu QW. Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method. J Nanopart Res 2010, doi: 10.1007/s11051-010-9998-y
   Google Scholar
• Luo YF, Chen DW, Ren LX, Zhao XL, Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release 2006; 114: 53–9
   PubMed Web of Science ®Google Scholar
• Maren TH. Carbonic anhydrase: Chemistry, physiology, and inhibition. Physiol Rev 1967; 47: 595–781
   PubMed Web of Science ®Google Scholar
• Muller RH, Mehnert W, Lucks JS, Schwarz C, Zur Muhlen A, Weyhers H, Freitas C, Rühl D. Solid lipid nanoparticles (SLN): An alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 1995; 41: 62–9
   Web of Science ®Google Scholar
• Palma SD, Tartara LI, Quinteros D, Allemandi DA, Longhi MR, Granero GE. An efficient ternary complex of acetazolamide with HP-ß-CD and TEA for topical ocular administration. J Control Release 2009; 138: 24–31
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 2002; 23: 3247–55
   PubMed Web of Science ®Google Scholar
• Schubert MA, Muller-Goymann CC. Characterisation of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm 2005; 61: 77–86
   PubMed Web of Science ®Google Scholar
• Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, Martone JF, Royall RM, Witt KA, Ezrine S. Racial differences in the cause-specific prevalence of blindness in east Baltimore. New Engl J Med 1991; 325: 1412–17
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004; 278: 71–7
   PubMed Web of Science ®Google Scholar
• Sultana Y, Jain R, Aqil M, Ali A. Review of ocular drug delivery. Curr Drug Deliv 2006; 3: 207–17
   PubMedGoogle Scholar
• Vandamme TF. Microemulsions as ocular drug delivery systems: Recent developments and future challenges. Prog Retin Eye Res 2002; 21: 15–34
   PubMed Web of Science ®Google Scholar
• Wakiyama N, Juni K, Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anaesthetics. Chem Pharm Bull 1981; 29: 3363–8
   PubMed Web of Science ®Google Scholar
• Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y. Drug delivery systems for vitreoretinal diseases. Prog Retin Eye Res 2004; 23: 253–81
   PubMed Web of Science ®Google Scholar
• Ye J, Wang Q, Zhou X, Zhang N. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm 2008; 352: 273–9
   PubMed Web of Science ®Google Scholar
• Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular drug delivery systems. Adv Drug Deliv Rev 1995; 16: 61–73
   Web of Science ®Google Scholar
• Zimmerman TJ. Acetazolamide and methazolamide. Ann Ophthalmol 1978; 10: 509–10
   Web of Science ®Google Scholar
• Zur Muhlen A, Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie 1998; 53: 552–5
   Web of Science ®Google Scholar